Abstract
To compare safety and efficacy of transcatheter arterial chemoembolization (TACE) with drug-eluting embolic agents combined with percutaneous ablation versus radioembolization (TARE) in treatment of treatment-naïve solitary unresectable hepatocellular carcinoma (HCC) ≥3cm
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
